• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Unpuzzling COVID-19 Prothrombotic State: Are Preexisting Thrombophilic Risk Profiles Responsible for Heterogenous Thrombotic Events?

作者信息

Burlacu Alexandru, Genovesi Simonetta, Popa Iolanda Valentina, Crisan-Dabija Radu

机构信息

Department of Interventional Cardiology-Cardiovascular Diseases Institute, Iasi, Romania.

'Grigore T. Popa' University of Medicine and Pharmacy, Iasi, Romania.

出版信息

Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620952884. doi: 10.1177/1076029620952884.

DOI:10.1177/1076029620952884
PMID:32842771
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7453448/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/954b/7453448/8231311ee35a/10.1177_1076029620952884-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/954b/7453448/8231311ee35a/10.1177_1076029620952884-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/954b/7453448/8231311ee35a/10.1177_1076029620952884-fig1.jpg

相似文献

1
Unpuzzling COVID-19 Prothrombotic State: Are Preexisting Thrombophilic Risk Profiles Responsible for Heterogenous Thrombotic Events?解开新冠病毒感染的血栓形成状态之谜：既往存在的易栓风险特征是否是导致血栓形成事件异质性的原因？
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620952884. doi: 10.1177/1076029620952884.
2
Context: How COVID-19 exposed key factors of emergency medicine education.背景：新冠疫情如何揭示了急诊医学教育的关键因素。
CJEM. 2020 Sep;22(5):561-562. doi: 10.1017/cem.2020.447.
3
Are We Ready for the New Coronavirus?我们准备好应对新型冠状病毒了吗？
Arch Bronconeumol (Engl Ed). 2020 Apr;56(4):195-196. doi: 10.1016/j.arbres.2020.02.009. Epub 2020 Mar 11.
4
Antiplatelet/anticoagulant agents for preventing thrombosis events in patients with severe COVID-19: A protocol for systematic review and meta-analysis.用于预防重症新型冠状病毒肺炎患者血栓形成事件的抗血小板/抗凝药物：一项系统评价和荟萃分析方案
Medicine (Baltimore). 2020 Aug 7;99(32):e21380. doi: 10.1097/MD.0000000000021380.
5
Potential influences of obstructive sleep apnea and obesity on COVID-19 severity.阻塞性睡眠呼吸暂停和肥胖对 COVID-19 严重程度的潜在影响。
J Clin Sleep Med. 2020 Sep 15;16(9):1645. doi: 10.5664/jcsm.8538.
6
ASE Statement on the Reintroduction of Echocardiographic Services during the COVID-19 Pandemic.美国超声心动图学会关于在 COVID-19 大流行期间重新引入超声心动图服务的声明。
J Am Soc Echocardiogr. 2020 Aug;33(8):1034-1039. doi: 10.1016/j.echo.2020.05.019. Epub 2020 May 20.
7
Urology surgical activity and COVID-19: risk assessment at the epidemic peak: a Parisian multicentre experience.泌尿外科手术活动与 COVID-19：疫情高峰期的风险评估：巴黎多中心经验
BJU Int. 2020 Oct;126(4):436-440. doi: 10.1111/bju.15164. Epub 2020 Aug 4.
8
Resurgence of covid-19 in Japan.新冠疫情在日本的卷土重来。
BMJ. 2020 Aug 18;370:m3221. doi: 10.1136/bmj.m3221.
9
A case series of novel coronavirus infection in heart transplantation from 2 centers in the pandemic area in the North of Italy.来自意大利北部疫区 2 家中心的心脏移植新型冠状病毒感染的病例系列。
J Heart Lung Transplant. 2020 Oct;39(10):1081-1088. doi: 10.1016/j.healun.2020.06.016. Epub 2020 Jun 26.
10
From SARS to COVID-19: the Singapore journey.从非典到新冠疫情：新加坡的历程。
Med J Aust. 2020 Jun;212(11):497-502.e1. doi: 10.5694/mja2.50623. Epub 2020 May 31.

引用本文的文献

1
Spinal cord injury and electrical stimulation: analysis of neuroplasticity in a case report.脊髓损伤与电刺激：一例报告中的神经可塑性分析
Front Rehabil Sci. 2025 Jun 19;6:1557010. doi: 10.3389/fresc.2025.1557010. eCollection 2025.
2
Acute Myocardial Infarction in a 9-Year-Old Boy Due to Multisystem Inflammatory Syndrome.一名9岁男孩因多系统炎症综合征引发急性心肌梗死。
Anatol J Cardiol. 2022 Jul;26(7):580-583. doi: 10.5152/AnatolJCardiol.2022.1491.
3
Association of polymorphisms in genes encoding prothrombotic and cardiovascular risk factors with disease severity in COVID-19 patients: A pilot study.

本文引用的文献

1
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19.新型冠状病毒肺炎患者的尸检结果与静脉血栓栓塞
Ann Intern Med. 2020 Dec 15;173(12):1030. doi: 10.7326/L20-1206.
2
4 Cases of Aortic Thrombosis in Patients With COVID-19.4例新冠肺炎患者发生主动脉血栓形成
JACC Case Rep. 2020 Jul 15;2(9):1397-1401. doi: 10.1016/j.jaccas.2020.06.003. Epub 2020 Jun 8.
3
A comprehensive assessment of the coagulation profile in critically ill COVID-19 patients.对危重症COVID-19患者凝血状况的全面评估。
基因编码促血栓形成和心血管危险因素的多态性与 COVID-19 患者疾病严重程度的相关性：一项初步研究。
J Med Virol. 2022 Aug;94(8):3669-3675. doi: 10.1002/jmv.27774. Epub 2022 Apr 21.
4
Comparative transcriptomic analysis of SARS-CoV-2 infected cell model systems reveals differential innate immune responses.比较 SARS-CoV-2 感染细胞模型系统的转录组分析揭示了不同的先天免疫反应。
Sci Rep. 2021 Aug 25;11(1):17146. doi: 10.1038/s41598-021-96462-w.
5
Anti-inflammatory role of curcumin in retinal disorders (Review).姜黄素在视网膜疾病中的抗炎作用（综述）
Exp Ther Med. 2021 Jul;22(1):790. doi: 10.3892/etm.2021.10222. Epub 2021 May 21.
6
Thrombotic Events in COVID-19: Inquires About the Deleterious Procoagulant Effect of Corticosteroid Therapy.新型冠状病毒肺炎中的血栓形成事件：关于皮质类固醇疗法有害促凝作用的探讨
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211020139. doi: 10.1177/10760296211020139.
7
A pilot study on the impact of congenital thrombophilia in COVID-19.一项关于先天性血栓形成倾向对新型冠状病毒肺炎影响的初步研究。
Eur J Clin Invest. 2021 May;51(5):e13546. doi: 10.1111/eci.13546. Epub 2021 Mar 25.
8
Recrudescence of livedoid vasculopathy induced by COVID-19.由新型冠状病毒肺炎（COVID-19）诱发的类癌样血管病复发
Int J Dermatol. 2021 May;60(5):e185-e187. doi: 10.1111/ijd.15423. Epub 2021 Feb 2.
9
Is Thrombophilic Genetic Profile Responsible for an Acute Ischemic Stroke in a COVID-19 Male Patient?血栓形成倾向基因谱是否是一名COVID-19男性患者急性缺血性中风的病因？
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620967107. doi: 10.1177/1076029620967107.
Thromb Res. 2020 Oct;194:42-44. doi: 10.1016/j.thromres.2020.06.026. Epub 2020 Jun 18.
4
Hemorrhagic stroke and anticoagulation in COVID-19.COVID-19 相关的出血性脑卒中与抗凝治疗。
J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104984. doi: 10.1016/j.jstrokecerebrovasdis.2020.104984. Epub 2020 May 23.
5
COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.COVID-19：凝血功能障碍、血栓形成风险和抗凝治疗的理由。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620938149. doi: 10.1177/1076029620938149.
6
Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020.2020 年新型冠状病毒病（COVID-19）患者抗栓治疗的循证实用指南。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620936350. doi: 10.1177/1076029620936350.
7
Glucose-6-Phosphate Dehydrogenase Deficiency: An Actionable Risk Factor for Patients with COVID-19?葡萄糖-6-磷酸脱氢酶缺乏症：COVID-19 患者的一个可干预风险因素？
Arch Med Res. 2020 Oct;51(7):743-744. doi: 10.1016/j.arcmed.2020.06.006. Epub 2020 Jun 7.
8
COVID-19 Is an Independent Risk Factor for Acute Ischemic Stroke.COVID-19 是急性缺血性脑卒中的独立危险因素。
AJNR Am J Neuroradiol. 2020 Aug;41(8):1361-1364. doi: 10.3174/ajnr.A6650. Epub 2020 Jun 25.
9
Microthrombotic Complications of COVID-19 Are Likely Due to Embolism of Circulating Endothelial Derived Ultralarge Von Willebrand Factor (eULVWF) Decorated-Platelet Strings.COVID-19的微血栓并发症可能是由于循环中内皮衍生的超大血管性血友病因子（eULVWF）修饰的血小板串的栓塞所致。
Fed Pract. 2020 Jun;37(6):e1-e2. Epub 2020 May 15.
10
Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19.科学与标准化委员会通讯：新型冠状病毒肺炎住院患者静脉血栓栓塞症诊断、预防及治疗的临床指南
J Thromb Haemost. 2020 Aug;18(8):1859-1865. doi: 10.1111/jth.14929.